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ABSTRACT 
THE EFFECT OF DOSAGE REGIMEN 
ON MEDICATION COMPLIANCE 
BY: ERNEST W. KEICH 
According to recent data, between 25% and 50% 
of patients are noncompliant in their therapy regimen 
in some manner. The fourth report of the Joint National 
Committee on the Detection, Evaluation, and Treatment of 
High Blood Pressure (Neal, 1989) states that noncompliance 
is the major problem in hypertension control. 
It was hypothesized there would be a difference in 
the compliance of hypertensive patients whose medication 
regimen consisted of single daily dosing as opposed to 
those patients whose regimen consisted of two or more 
times a day dosing. 
Potential subjects for the study were hypertensive 
patients selected from a rural, southeastern Georgia 
setting who patronized a local pharmacy. The pharmacy's 
records from January 1, 1989 through October 15, 1991 were 
accessed to identify patients prescribed only antihyper- 
tensive therapy and whose therapy had been consistent for 
at least fourteen months. Fifty-five subjects met this 
criteria. 
A data collection form was developed so that infor¬ 
mation from pharmaceutical records (computerized and 
i v 
printed patient profiles) could be obtained in a 
standardized manner. The form consisted of 
twelve questions which addressed demographics, types 
of medication, physician information, payor type, and 
medication therapy. 
From the information obtained, the relationship 
between ten variables (age, gender, town of residence, 
race, marital status, payor type, whether subject had 
children, class of medication, physician setting, 
medication regimen) and compliance percentage was analyzed. 
Analysis of data was accomplished by univariate and multi- 
variate analysis of variance (ANOVA) to test for signifi¬ 
cant differences between compliance percentage and the 
factors of interest for the study. 
Dosage regimen (once a day versus two or more 
times a day) was the only statistically significant 
factor related to compliance percentage. 
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INTRODUCTION 
The problem of patient compliance in drug therapy 
continues to be a major concern for healthcare providers, 
and the subject of much research. Much of this research 
centers around the effects of noncompliance in antihyper- 
tensive therapy. This noncompliance hinders effective 
treatment by physicians often needlessly prolonging the 
time necessary to stabilize the blood pressure of patients. 
The lack of compliance has also resulted in otherwise un¬ 
necessary hospital admissions due to complications of unman- 
aged hypertension (Chan, Larsen, Laventurier, Strandberg, 
& Sullivan, 1989). 
Noncompliance in the treatment of hypertension is 
a multi-faceted problem. Up to 30% of prescriptions 
written for antihypertensives are never filled. Many 
patients fail to have their prescriptions refilled on 
time. Often follow-up appointments with physicians are 
never kept. Most hypertensive patients average 3.6 pre¬ 
scriptions which they must administer themselves. This 
multi-drug therapy may lead to confusion and memory lapse 
resulting in medications being taken improperly (Redder, 
1990). 
All of the above offer an opportunity to hinder 
medication compliance. Perhaps the most effective aspect 
that would improve this compliance would be to simpli- 
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fy drug therapy. Simplification could be accomplished 
in two ways: First, through the use of combination 
products, if a patient is now taking two separate 
blood pressure medications, perhaps he could be pre¬ 
scribed a product which combines the two drugs, thereby 
reducing the total number of medications consumed; 
second, by reducing the number of daily doses of medication, 
if possible offering a regimen of once a day dosing rather 
than more frequent daily dosing. 
PURPOSE 
The purpose of this study was to investigate the 
effect of a once a day medication dosage regimen as 
opposed to more frequent daily dosing on the compliance 
of hypertensive patients. The compliance percentages for 
hypertensive patients were calculated and the relationship 
of dosage regimens examined. 
SIGNIFICANCE 
Uncontrolled hypertension can have severe health 
complications. These complications can manifest them¬ 
selves in the form of coronary disease, cerebral vas¬ 
cular accidents (commonly called strokes), myocardial 
infarction, or other ischemic diseases. Among the black 
population, hypertension is primarily responsible for 
their high mortality rates from heart and kidney disease 
and stroke (Coleman, 1990). 
Improper medication administration has been shown 
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to prolong illness and contribute to hospitalization. 
Concerning hospitalization, Chan et al (1989) reported 
that the ratio of days without antihypertensive drugs was 
significantly higher in a re-admit group of patients 
as compared with a no re-admit group of patients. 
At a time when the nation is alarmed at the rocketing 
costs of health care, especially hospitalization; the ex¬ 
ploration of every avenue to enhance favorable patient 
outcomes has gained importance. With the advent of potent 
antihypertensive drugs, noncompliance has become the most 
limiting factor in the management of hypertension (Luscher 
& Vetter, 1 990 ) . 
HYPOTHESIS 
There is a statistically significant difference in 
the mean compliance percentage of hypertensive patients 
whose medication regimens consist of once a day dosing 
as opposed to those patients whose regimens consist of 
more frequent daily dosing. 
DEFINITIONS 
(1) Compliance the extent to which a patient ob¬ 
tained from the pharmacy his medication as 
scheduled. 
(2) Dosage regimen the prescribed medications, 
their routes of administration, and their 
dosage frequencies as indicated for an individ¬ 
ual's course of therapy. 
(3) Combination medication a compound containing 
two or more antihypertensive medications in a 
single dosage form. 
(4) Compliance percentage refers to the percentage 
obtained by dividing the number of pills or dosage 
forms the customer purchased during the time 
period of study by the number of pills prescribed 
by the physician during the time period of study. 
For patients on more than one antihypertensive 
medication, the medication having the lowest 
compliance will be used in determining this 
percentage. 
ASSUMPTIONS 
The study assumed that the number of pills bought 
by patients was equal to the number of pills they con¬ 
sumed. The assumption was also made that the patients 
frequented only the pharmacy chosen for the study as their 
single source of prescription medications. 
LIMITATIONS 
The study had several limitations, primarily result¬ 
ing from the information available on the pharmaceutical 
records. The importance placed on the physician's influence 
by each patient was not measured. The amount of health 
knowledge possessed by each patient was not determined. 
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The amount of family support and encouragement was not 
measured. The patient's understanding of his regimen was 
not accessed; nor was the impact of side effects on the 
patient's adherence to his medication regimen. 
Additional limitations included: the lack of in¬ 
formation on the patient's marital adjustment; the lack 
of a mechanism to determine if the physician may 
have given the patient oral instructions different from 
the written prescription; and the lack of sufficient age 
data so as to be able to determine the impact this 
variable had on the resulting compliance percentages. 
The cost of the medication and whether or not the 
patient properly monitored his blood pressure also were 
not assessed. 
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CHAPTER 2 LITERATURE REVIEW 
The lack of drug compliance is recognized by health¬ 
care practioners as a major health problem. The degree 
and extent to which this problem manifests itself has been 
the subject of many research efforts. This type of research 
has proven to be difficult due to the numerous definitions 
used for the term "compliance" by the various investigators 
(Luscher, Siegenthaler, H. Vetter, & W. Vetter, 1985). 
In a recent work reviewing fourteen studies on 
medication compliance, Luscher, et. al. (1985) reported 
that twelve different definitions for compliance were 
utilized. Two studies used "mean compliance rate" as their 
definition of compliance and two studies defined compliance 
as greater than 80% of pills taken. Results of these 
studies yeilded compliance percentages ranging from 19% 
to 87%. The lack of standardization of definition for 
compliance might explain some of the differences found 
in these studies. 
Although there is no firmly established definition 
for compliance, researchers have spent much effort in 
determining factors which contribute to non-compliance. 
These factors range from psychological and personal choice 
behaviors to drug therapy and treatment specific aspects. 
Seventeen studies were reviewed to determine factors 
associated with compliance percentage. The relationship 
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of the following factors and their impact on medication 
compliance was explored. 
Although the amount of "physician influence" was 
mentioned as a factor related to compliance (Neal, 1989; 
Cadoret, Troughton, & Widmer, 1983), no empirical data 
was presented to support this relationship. Anecdotally, 
however, many patients will comply with their regimen only 
if encouraged by their physician (Neal, 1989). 
Overall health knowledge of the patient is 
another factor considered related to compliance. However, 
review of the literature revealed relatively little sup¬ 
port for a strong correlation between the two (Klein, 
1988) and no statistical data was presented for Klein's 
study. 
How well the patient understands his medication 
regimen was discussed as a contributing factor in com¬ 
pliance. The Virginia affiliate of The American Heart 
Association surveyed 425 physicians as to why they felt 
some of their patients did not adequately control their 
hypertension. The lack of understanding of medication 
regimen by the patient was the major reason given in 82% 
of the cases of uncontrolled hypertension (Moore, 1988). 
Studies also concentrated on patient education and 
compliance counseling. Black, Elden, Geary, Hovell, 
Kamachi, and Kirk (1985) found an increase from 60% to 
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100% in compliance percentage after patient counseling. 
Moore (1988) found that frequent blood pressure monitor¬ 
ing improved compliance in some patients. This study 
recommended company sponsored blood pressure monitoring 
in the work place. 
Physician setting was mentioned as having an 
affect on compliance, but only in a single study which 
did not present statistical data (Neal, 1989). This 
study found that patients seeing physicians in private 
settings demonstrated better compliance than those seeing 
physicians in clinic settings. 
In 1990, Groff, Jono, Trevino and Young reported a 
relationship between marital adjustment and remembering 
to take blood pressure medication. They used a 32-item 
Dyadic Adjustment Scale to measure the subject's per¬ 
ception of affection, consensus, cohesion and satisfac¬ 
tion in marriage. This study supported the concept that 
better marital adjustment does contribute to greater com¬ 
pliance with prescribed medical regimens. 
The effect of the amount of family support has also 
been found to be a determinant of medication compliance. 
The extent to which the patient obtains support from 
family members was stated as being directly related to 
a patient's compliance (Cadoret, Troughton, & Widmer, 1983). 
9 
However, no statistical data relating to this factor was 
presented. 
An obvious reason for a patient being unable to 
comply is the cost of medication. Although cost was 
discussed as a factor for compliance, no statistical data 
relating medication expense to compliance was presented 
in a study by Fletcher (1989). 
Both age and side effects were also the focus of 
research related to medication compliance. Interestingly, 
in reviewing literature on compliance, age was a factor 
seldom considered in this research. Klein (1988) found 
that the elderly patients try very hard to be compliant. 
This study quoted two reports: the Maryland Statewide 
Hypertension Survey as reported by Entwisle, German, Klein, 
Levine and Southard (1984), found that the patients most 
likely to be actively taking their medication were the 
elderly; and a report from the National, Heart, Lung, and 
Blood Institute (Haines & Ward, 1981) which stated that, 
"Younger hypertensives were more likely to discontinue 
their medications than older ones". 
Side effects were discussed in two studies as a 
factor possibly impacting compliance; however, the results 
were conflicting. The first study was directed at how 
physicians could improve their patients medication com¬ 
pliance. In this study Moore, (1988) found that side 
1 0 
effects, whether real or perceived, are often a cause for 
patients to discontinue their medication. However, Klein 
(1988) reported that the inverse relationship of compliance 
and side effects was very weak and possibly of limited 
clinical importance. 
The effect of race and gender on medication com¬ 
pliance was considered. Moore (1988) found that 
inadequate hypertension control was most fequent in young 
blacks and that a major factor contributing to this lack 
of control was non-compliance with antihypertensive therapy. 
Chan et al (1989) found in a study of underutilization 
of antihypertensive drugs and associated hospital 
re-admissions, 61% were black and 64% were female. Luscher 
and Vetter (1990) found that dropouts during antihyper¬ 
tensive therapy tended to be male and of low socioeconomic 
status. However, this study also stated that patient 
characteristics such as sex and race were unreliable 
predictors of compliance with medication therapy. 
Two additional factors affecting compliance appear¬ 
ed in more studies than any other. The first was the 
number of different medications taken by the patient. 
The second was the number of times a day the patient had 
to take each medication. Much of the literature describing 
these two factors stressed simplification of the patients 
drug therapy. It is strongly recommended that for increased 
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compliance, the medication therapy should be simple and, 
if possible, a once-a-day dosing regimen (Morgan, Murphy, 
Nowson, & Snowdon, 1986). Another recommendation is to 
prescribe combination medications. The combination 
medications would enhance compliance by reducing the total 
number of pills taken each day and because they are usually 
less costly (Moore, 1988). 
As is evidenced, the impact of non-compliance is great 
both in terms of monetary and health costs. The con¬ 
tributory factors are many; some easier to manipulate 
than others. Prescribing a simpler dosage regimen 
certainly appears to offer a measurable positive affect 
on medication compliance. 
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CHAPTER 3 METHODOLOGY 
This study was an indepth case study of selected 
hypertensive patients in an effort to determine the 
relationship of drug regimen and medication compliance. 
A twelve question data collection tool was developed 
and utilized to record accumulated information of 
medication purchases in a standardized manner. 
The population consisted of hypertensive patients 
receiving medications from a pharmacy in a rural setting. 
The pharmacy was located in a town of approximately 2000 
people. There was not another pharmacy within an eight 
mile radius of the one chosen for this investigation. The 
county and town were mid-to-lower economic areas with little 
industrial development and were largely agriculturally based. 
Since registered pharmacists have legal access 
to patient records and are required by professional 
ethics to maintain patient confidentiality, there was 
no need to obtain permission to review records from the 
subjects. Printed and computerized profiles from January 
1, 1989 to October 15, 1991 were reviewed retrospectively 
for all patients utilizing the pharmacy. 
Hypertensive patients who met the following criteria 
were selected as the sample for the study. First, that 
they were taking only antihypertensive medications during 
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this study period. This criteria implied that the patient 
was taking a "pure" medication regimen (no other medica¬ 
tions were prescribed). Second, that they were taking 
the same regimen of antihypertensives for at least fourteen 
months. This second criteria implied the following: 
that the patient's blood pressure was stablilized and 
there was no need to change medication regimen, that the 
patient was compliant, and the patient was experiencing 
no significant side effects. 
Each eligible patient was assigned an unique 
indentification number which was used instead of a patient's 
name on all data abstraction forms. All information 
relating the patient's name to his identification number 
was destroyed; thus, ensuring confidentiality. 
For each patient, the principle researcher completed 
a "Hypertensive Patient Data Collection Form" (See 
appendix A). Information was abstracted from the phar¬ 
macy's patient profiles. This information included the 
following: age, gender, zip code, race, marital status, 
payor type (private, medicaid, third party, or other), 
whether the patient had children, class of medication 
purchased, physician setting (private or clinic), medication 
regimen (once a day, twice daily, three times daily, four 
times daily, five times daily or more), medication name, 
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and compliance percentage. 
The compliance percentage for each patient was 
determined by dividing the number of pills that the 
patient purchased over at least a fourteen month period 
(the numerator) by the number of pills that should 
have been taken for the same time period as determined 
by the recorded medication dosage regimen (the denomi- 
ator). For patients on multiple hypertensive medications, 
the medication having the lowest compliance 
was used in determining this percentage. This method 
was selected since the most consistent a subject could 
be in terms of medication compliance would be indicated 
by their lowest compliance percentage. 
The statistical technique used to test the study's 
hypothesis was analysis of variance. A one-way analy¬ 
sis of variance was used to assess the relationship of 
compliance percentage and each categorical variable in¬ 
cluded in the study. Comparisons were considered sig¬ 
nificantly different if a p-value of .05 or less was com¬ 
puted. For regimen, a dichotomous variable was created: 
1) Those patients who took their medications once daily; 
2) Those who took their medications two or more times per 
day. 
A multivariable ANOVA model was constructed to test 
the relationship between regimen and compliance when ad- 
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justing for race and gender. These two variables were 
associated with compliance rate in other studies 
(Chan et al, 1 989) . 
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CHAPTER 4 ANALYSIS AND FINDINGS 
Fifty-five pharmacy patrons met the study's inclu¬ 
sion criteria. Information abstracted for these subjects 
utilizing the "Hypertensive Patient Data Collection Form" 
(Appendix A) was used for the analysis. Statistical 
analysis of the data was performed using the Statistical 
Package for Social Science (Norusis, 1988). 
There were two continuous variables considered in 
the study; age and compliance percentage (Table I). For 
the fifty five subjects, age information was available 
for eighteen patients only. The mean age for these 
eighteen patients was 60.78 years. The mean compliance 
percentage for the sample was 83.25%. 
TABLE I 
DESCRIPTION OF CONTINUOUS VARIABLES 
OF SAMPLE 
FACTOR NUMBER MEAN STD. DEV 
Age(years) 1 8 60.78 13.49 
Compliance 
Percentage 55 83.25 17.75 
Frequencies and percentages of the categorical 
factors included in the study are reported in Table II. 
TABLE II. 
DESCRIPTION OF CATEGORICAL VARIABLES 
OF SAMPLE 
FACTOR NUMBER PERCENTAGE 
Gender 
a) Male 31 56.4 
b) Female 24 4316 
Town of Residence 
a) Rincon 5 
b) Springfield 26 4713 
c) Guyton 13 23*fi 
d) Eden 3*6 
e) Clyo 7 ,2\l 
Missing data 2 3^5 
Race 
a) White 40 72.7 
b) Black 14 25.5 
Missing data  i^g 
Marital Status 
a) Married 42 76.4 
b) Divorced 1 1.3 
c) Widowed 10 18.2 
Missing data 2 3.5 
Payor Type 
a) Private 46 83.6 
b) Medicaid 1 1.3 
c) Third party 3 5.5 
d) Other 5 g.i 
Has Children 
a) Yes 48 37.3 
b) No 5 9.1 
Missing data 2 3,5 
Class of Medication 
a) Diuretic 3 5,5 
b) Antiadrenergic 7 12.7 
c) Calcium blocker 11 20.0 
d) Ace-inhibitor 19 34.5 
e) Combination 14 25.5 
f) Other  1.8 
Physician Setting 
a) Private 49 89.1 
b) Clinic 6 10.9 
Medication Regimen 
a) Once daily 33 60.0 
b) Twice daily 18 32.7 
c) Three times/day 3 5,5 
d) Every other day 1 1.3 
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The sample was predominantly male (56.4%) and mar¬ 
ried (76.4%). The majority (70.9%) of the subjects re¬ 
sided in two towns, Springfield and Guyton. The majority 
(72.7%) of the sample was white and had children (87.3%). 
The sample was predominantly (83.6%) private pay and 80.0% 
of the subjects received one of three classes of medication: 
calcium channel blockers, ace-inhibitors or a combination 
product. The majority (89.1%) of the patients saw 
physicians in private settings and were on a once-a-day 
medication regimen (60.0%). 
The results of one-way analysis of variance (ANOVA) 
are presented in Table III. From this analysis, the 
only study factor to show a significant relationship in 
effecting compliance percentage was medication regimen 
(89.14 versus 74.6 mean percentage, p= 0.0026). 
In the multivariable ANOVA model which included com¬ 
pliance percentage (dependent variable), regimen, race, 
and gender; regimen was again found to be statistically 
significant (p= 0.006). The mean percentage for once 
a-day was 89.15, and the mean percentage for two or more 
times a day was 75.05. Race and gender were not signifi¬ 
cantly related to compliance percentage. 
TABLE III. 
UNIVARIATE ANALYSIS COMPARING MEAN 
COMPLIANCE PERCENTAGE FOR SELECT STUDY FACTORS 
FACTOR NUMBER MEAN 
PROB- 
STD DEV ABILITY 
Gender 
a) Males 31 80.83 20.15 
b) Females 24 86.37 13.86 
Town of Residence 
a) Rincon 5 79.64 32.27 
b) Spring¬ 
field 26 82.52 17.57 
c) Guyton 1 3 82.64 16.46 
d) Eden 2 93.90 4.67 
e) Clyo 7 84.11 14.68 
Race 
a) White 40 83.30 19.00 
b) Black 1 4 84.36 14.16 
Marital Status 
a) Married 42 83.07 17.82 
b) Divorced 1 74.80 00.00 
c) Widowed 10 85.33 19.44 
Payor Type 
a) Private 46 82.35 18.51 
b) Medicaid 1 99.20 00.00 
c) Third pty. 3 83.30 14.52 
d) Other 5 88.28 1 3.84 
Has Children 
a) Yes 48 82.08 18.25 
b) No 5 95.48 4.61 
Physician Setting 
a) Private 49 82.39 18.15 
b) Clinic 6 90.23 13.27 
Class of 
Medication 
a) Diuretic 3 94.90 4.33 
b) Anti- 
adrenergic 7 85.53 15.45 
c) Calcium 
Blocker 11 78.16 26.95 
d) Ace- 
inhibitor 19 85.85 13.93 
e) Combin¬ 
ation 1 4 79.56 16.86 
f) other 1 90.40 00.00 
Regimen 
a) Once/day 33 89.1 4 11.12 
b) 2 or more 
times/day 21 74.60 22.56 
0.2550 
0.9224 
0.8490 
0.8394 
0.7338 
0.1107 
0.3118 
0.6438 
,0026* 
* p <.05 
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DISCUSSION AND CONCLUSIONS 
This study was unique in the selective nature of the 
sample. No other research that was reviewed included 
patients taking only antihypertensive medications or 
required the subjects to remain on the same antihypertensiv 
medication regimen for an extended period of time, such 
as fourteen months. 
The implications resulting from this criteria were 
that the subjects' medication regimens were "pure" (they 
were not taking other medications); that the subjects' 
blood pressures were stabilized, thus there was no need 
to change medication regimens; that the subjects were 
experiencing no significant side effects; and that they 
were for the most part compliant. 
These implications suggest a very specific population 
which may affect generalizability of the study results. 
However, this select study sample enhances the internal 
validity of the results in a way no other study has to 
date. Specifically, in showing that within this highly 
compliant group, once-a-day regimens showed significantly 
higher compliance than two or more times a day regimens. 
Based on the information presented in this study, 
the impact of dosage regimen on compliance percentage 
is apparent. Those patients whose regimen consists of 
21 
once a day therapy had a significantly higher (p=0.0026) 
compliance percentage (89.14%) than those patients taking 
the medications two or more times a day (74.6%). This 
relationship also held after adjusting for age and gender. 
The mean compliance percentages found in this study com¬ 
pared closely to those found in similar studies. Cadoret, 
Troughton, and Widmer (1983) found a mean compliance 
percentage of 87.5% for patients taking medications once 
or twice a day and 78% for patients taking medications 
three or four times a day. 
This study supports efforts to educate physicians 
to utilize newer antihypertensive medications which are 
taken once a day. It should be noted that 40% of the 
subjects in this study were on a more than once-a-day 
regimen. If patients can be switched to once-a-day 
medication and safely stabilized, then better compliance 
should be attained and ultimately lead to more effective 
blood pressure control. 
Although this study did show a significant rela¬ 
tionship between compliance percentage and regimen, the 
small size of the sample may have diminished statistical 
importance of other study factors. In addition, 
the source of information, pharmacy patient profiles, 
lacked data for certain variables. These missing data 
included health knowledge of subject, patient's understand¬ 
ing of his medication regimen, patient's marital adjustment, 
22 
whether the subject properly monitored his blood pressure, 
and if the physician may have given the patient oral 
instructions different from the written prescription. 
No statement of their impact on compliance percentage in 
this study can be offered. 
The assessment of the effect of age on compliance 
was also limited in the study because of the sparsity of 
data. However, a univariate ANOVA model (n=18) 
examining compliance rate and age found no significant 
relationship between these two variables. Other authors 
stated that the elderly were more compliant (Klein, 1988). 
Further research is indicated on the possible relation¬ 
ships of other factors (side effects, cost of medications, 
and patient's understanding of regimen) and their affect 
on compliance percentage, not only to produce new findings 
but also to add support to the findings of this study. 
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HYPERTENSIVE PATIENT DATA COLLECTION 
FORM 
1. I.D. # 
2. Birthdate: Month  Day  Year 
3. Gender (Circle): (1 - male, 2 - female) 
4. Zip Code  
5. Race (Circle): (1 - white, 2 - black, 3 - asian, 
4 - hispanic, 5 - other) 
6. Martial Status (Circle): (1 - married, 2 - single, 
3 - divorced, 4 - widowed) 
7. Payor Type (Circle): (1 - private, 2 - medicaid, 
3 - third party, 4 - other) 
8. Children (Circle): (1 - yes, 2 - no) 
9. Medication Class (Circle): (1- diuretic, 2- antiadrenergic, 
3- calcium channel blocker, 
4- ACE-inhibitor, 5-vasodilator 
6- combination, 7- other) 
10. Physician's name:  
11. Physician's practice setting (Circle): (1- private 2- clinic) 
12. a) Regimen #1 Drug #1 Drug #2 Drug #3 
medication name      
date began      
#times/day      
#dosages/adminis.       
date discontinued      
# of dosages should 
have taken 
# of dosages 
actually taken 
Regimen #2 Drug #l Drug #2 Drug #3 
medication name   
date began  
#times/day       
ttdosages/adminis.       
date discontinued      
# of dosages should 
have taken      
# of dosages 
actually taken       
Regimen #3 Drug #1 Drug #2 Drug #3 
medication name      
date began      
#times/day      
ttdosages/adminis.       
date discontinued      
# of dosages should 
have taken      
# of dosages 
actually taken      
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Abstract 
According to recent data between 25% and 50% of 
Patients are noncompliant in their therapy regimen in 
in some manner. The purpose of this study was to determine 
the relationship of the frequency of daily doses and 
medication compliance of hypertensive patients. The sub¬ 
jects of the study were fifty-five patients who were pre¬ 
scribed only antihypertensive therapy and whose therapy 
had been consistent for at least fourteen months. Pharmacy 
records were accessed to determine the compliance of these 
subjects. Patients on a once-a-day regimen demonstrated 
a statistically significant (p= 0.0026) different mean 
compliance percentage of 89.14% compared to a mean com¬ 
pliance percentage of 74.6% for those on a two or more 
times a day regimen. 
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INTRODUCTION 
The problem of patient compliance in drug therapy 
continues to be a major concern for healthcare providers, 
and the subject of much research. Much of this research 
centers around the effects of noncompliance in antihyper- 
tensive therapy. Noncompliance hinders effective treat¬ 
ment by physicians, often needlessly prolonging the 
time necessary to stabilize the blood pressure of patients. 
Lack of compliance has also resulted in otherwise unneces¬ 
sary hospital admissions due to complications of unmanaged 
hypertension (1). 
Noncompliance in the treatment of hypertension is 
a multi-faceted problem. Up to 30% of prescriptions 
written for antihypertensives are never filled. Many 
patients fail to have their prescriptions refilled on 
time. Often follow-up appointments with physicians are 
never kept. Most hypertensive patients average 3.6 pre¬ 
scriptions for different medications which they must 
administer themselves. This multi-drug therapy may lead 
to confusion and memory lapse resulting in medications 
being taken improperly (2). 
All of the above indicate that lack of medication 
MEDICATION COMPLIANCE 
4 
compliance is a major hindrance to the treatment of hyper¬ 
tension. Perhaps the most effective aspect that would 
improve this compliance would be to simplify drug therapy. 
Simplification could be accomplished in two ways. First, 
through the use of combination products. If a patient 
is now taking two separate blood pressure medications, 
perhaps he could be prescribed a product which combines 
the two drugs, thereby reducing the total number of 
medications consumed. The second method of simplication 
would be to reduce the number of daily doses of medication; 
if possible offer a regimen of once a day dosing rather 
than more frequent daily dosing. 
The purpose of this study was to investigate the 
effect of a once a day medication dosage regimen on the 
compliance of hypertensive patients as opposed to more 
frequent daily dosing. The compliance percentages for 
hypertensive patients were calculated by dividing the 
number of pills purchased during the time period of study 
by the number the number of pills prescribed by the 
physician during the time period of study. For patients 
on more than one antihypertensive medication, the medic¬ 
ation having the lowest compliance was used in deter- 
ming this percentage. 
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Methods 
The population consisted of hypertensive patients 
receiving medications from a pharmacy in a rural setting. 
The pharmacy was located in a town of approximately 2000 
people. There was not another pharmacy within a nine mile 
radius of the one chosen for this investigation. The county 
and town were mid-to-lower economic areas with little 
industrial development and largely agriculturally based. 
Hypertensive patients who met the following criteria 
were selected as the sample for the study. First, that 
they were taking only antihypertensive medications during 
this study period. This criteria implied that the patient 
was taking a "pure" medication regimen (no other medica¬ 
tions were prescribed). Second, that they were taking 
the same regimen of antihypertensives for at least fourteen 
months. This second criteria implied the following: 
that the patient's blood pressure was stablilized and 
there was no need to change medication regimen, that the 
patient was compliant, and the patient was experiencing 
no significant side effects. Based on these requirements, 
fifty-five patients were included in the study. Each 
patient was assigned an unique indentification number which 
was used instead of a patient's name on all data abstraction 
forms. All information relating the patient's name to 
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his identification number was destroyed; thus, ensuring 
confidentiality. 
Since registered pharmacists have legal access 
to patient records and are required by professional 
ethics to maintain patient confidentiality, there was 
no need to obtain permission to review records from the 
subjects. Printed and computerized profiles from January 
1, 1989 to October 15, 1991 were reviewed retrospectively 
for all patients patronizing the pharmacy. 
A twelve question data collection tool was developed 
and utilized to retrieve accumulated information of 
medication purchases in a standardized manner. For each 
patient, the principle researcher completed the 
"Hypertensive Patient Data Collection Form". Information 
abstracted from the pharmacy's patient profiles included 
the following: age, gender, zip code, race, marital status, 
payor type (private, medicaid, third party, or other), 
whether the patient had children, class of medication 
purchased, physician setting (private or clinic), medication 
regimen (once a day, twice daily, three times daily, four 
times daily, five times daily or more), medication name, 
and compliance percentage. 
The compliance percentage for each patient was 
determined by dividing the number of pills that the 
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psticnt purchased over at least a fourteen month period 
by the number of pills that should have been taken for 
the same time period as determined by the recorded 
medication dosage regimen. For patients on multiple 
hypertensive medications, the medication having the lowest 
compliance was used in determining this percentage. This 
method was selected since the most consistent a subject 
could be in terms of medication compliance would be 
indicated by their lowest compliance percentage. 
The statistical technique used to test the study's 
hypothesis was analysis of variance. A one-way analy¬ 
sis of variance was used to assess the relationship of 
compliance percentage and each categorical variable in¬ 
cluded in the study. Comparisons were considered sig¬ 
nificantly different if a p-value of .05 or less was com¬ 
puted. For regimen, a dichotomous variable was created: 
1) Those patients who took their medications once daily; 
2) Those who took their medications two or more times per 
day. 
A multivariable ANOVA model was constructed to test 
the relationship between regimen and compliance when ad¬ 
justing for race and gender. These two variables were 
commonly associated with compliance rate in other 
studies (1). 
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Results 
Statistieal analysis of the data was performed 
using the Statistical Package for Social Science (4). 
Information abstracted for the fifty-five subjects 
utilizing the "Hypertensive Patient Data Collection Form" 
was used for the analysis. 
There were two continuous variables considered in 
the study; age and compliance percentage (Table I). For 
the fifty five subjects, age information was available 
for eighteen patients only. The mean age for these 
eighteen patients was 60.78 years. The mean compliance 
percentage for the sample was 83.25%. 
TABLE I. 
DESCRIPTION OF CONTINUOUS VARIABLES 
OF SAMPLE 
FACTOR NUMBER MEAN STD. DEV. 
Age(years) 1 8 60.78 1 3.49 
Compliance 
percentage 55 83.25 1 7.75 
Frequencies and percentages of the categorical 
factors included in the study are reported in Table II. 
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TABLE II. 
DESCRIPTION OF CATEGORICAL VARIABLES 
OF SAMPLE 
FACTOR NUMBER PERCENTAGE 
Gender 
a) Male 31 56.4 
b) Female 24 
b) Town II. 26 
43.6 
Town of Residence 
a) Town 1. 5 g. i 
47.3 
c) Town III. 13 23 6 
d) Town IV.  gjg 
e) Town V. 7 12]7 
Missing data 2 3.5 
Race 
a) White 40 72.7 
b) Black 14 25.5 
Missing data  1.3 
Marital Status 
a) Married 42 76.4 
b) Divorced 1 1.3 
c) Widowed 10 18.2 
Missing data 2 3.6 
Payor Type 
a) Private 46 83.6 
b) Medicaid 1 1.3 
c) Third party 3 5.5 
d) Other 5 9.1 
Has Children 
a) Yes 48 37.3 
b) No 5 9.1 
Missing data 2 3.6 
Class of Medication 
a) Diuretic 3 5.5 
b) Antiadrenergic 7 12.7 
c) Calcium blocker 11 20.0 
d) Ace-inhibitor 19 34.5 
e) Combination 14 25.5 
f) Other  1.8 
Physician Setting 
a) Private 49 89.1 
b) Clinic 6 10.9 
Medication Regimen 
a) Once daily 33 60.0 
b) Twice daily 18 32.7 
c) Three times/day 3 5.5 
d) Every other day  1«8 
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The sample was predominantly male (56.4%) and mar¬ 
ried (76.4%). The majority (70.9%) of the subjects re¬ 
sided in two towns. The majority (72.7%) of the sample 
was white and had children (87.3%). The sample was 
predominantly (83.6%) private pay and 80.0% of the subjects 
received one of three classes of medication: calcium 
channel blockers, ace-inhibitors or a combination 
product. The majority (89.1%) of the patients saw 
physicians in private settings and were on a once-a-day 
medication regimen (60.0%). 
The results of one-way analysis of variance (ANOVA) 
are presented in Table III. From this analysis, the 
only study factor to show a significant relationship in 
effecting compliance percentage was medication regimen 
(89.1 versus 74.6 mean percentage at a p = 0.0026). 
In the multivariable ANOVA model which adjusted for 
race and gender, regimen was again found to be significant¬ 
ly different at p= 0.006 (89.15 mean percentage for once- 
a-day versus 75.05 mean percentage for two or more times 
a day). 
Discussion 
This study was unique in the selective nature of the 
sample. No other research reviewed considered patients 
taking only antihypertensive medications or required the 
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TABLE HI. 
UNIVARIATE ANALYSIS COMPARING MEAN 
COMPLIANCE PERCENTAGE FOR SELECT STUDY FACTORS 
FACTOR NUMBER MEAN STD DEV 
Gender 
a) Males 31 80.83 20.15 
b) Females 24 86.37 13.86 
Town of Residence 
a) Town I. 5 79.64 32.27 
b) Town II. 26 82.52 17.57 
c) Town III. 13 82.64 16.46 
d) Town IV. 2 93.90 4.67 
e) Town V. 7 84.11 14.68 
Race 
a) White 40 83.30 19.00 
b) Black 1 4 84.36 14.16 
Marital Status 
a) Married 42 83.07 17.82 
b) Divorced 1 74.80 00.00 
c) Widowed 10 85.33 19.44 
Payor Type 
a) Private 46 82.35 18.51 
b) Medicaid 1 99.20 00.00 
c) Third pty. 3 83.30 14.52 
d) Other 5 88.28 13.84 
Has Children 
a) Yes 48 82.08 18.25 
b) No 5 95.48 4.61 
Physician Setting 
a) Private 49 82.39 18.15 
b) Clinic 6 90.23 13.27 
Class of 
Medication 
a) Diuretic 3 94.90 4.33 
b) Anti- 
adrenergic 7 85.53 15.45 
c) Calcium 
Blocker 11 78.16 26.95 
d) Ace- 
inhibitor 19 85.85 13.93 
e) Combin¬ 
ation 1 4 79.56 16.86 
f) other 1 90.40 00.00 
Regimen 
a) Once/day 33 89.14 11.12 
b) 2 or more 
times/day 21 74.60 22.56 
PROB- 
ABILITY 
0.2550 
0.9224 
0.8490 
0.8394 
0.7338 
0.1107 
0.3118 
0.6438 
.0026* 
* p <.05 
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subjects to remain on the same antihypertensive medication 
regimen for an extended period of time such as fourteen 
months. 
The implications resulting from this criteria were 
that the subjects' medication regimens were "pure" (they 
were not taking other prescription medications); that 
the subjects' blood pressures were stabilized thus there 
was no need to change medication regimens; that the 
subjects were experiencing no significant side effects; 
and that they were compliant. 
These implications suggest a very specific population 
which may affect generalizability of the study results. 
However, this select study sample enhances the internal 
validity of the results in a way no other study has to 
date. Specifically, in showing that within highly compliant 
groups, once-a-day regimens showed significantly higher 
compliance than two or more times a day regimens. 
Based on the information presented in this study, 
the impact of dosage regimen on compliance percentage 
is apparent. Those patients whose regimen consists of 
once a day therapy had a significantly higher (p=0.0026) 
compliance percentage (89.14%) than those patients taking 
the medications two or more times a day (74.6%). This 
relationship also held after adjusting for age and gender. 
The mean compliance percentages found in this study com- 
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pared closely to those found in similar studies. Cadoret, 
Troughton, and Widmer(5) found a mean compliance 
percentage of 87.5% for patients taking medications once 
or twice a day and 78% for patients taking medications 
three or four times a day. 
This study supports efforts to educate physicians 
to utilize newer antihypertensive medications which are 
taken once a day. It should be noted that 40% of the 
subjects in this study were on a more than once-a-day 
regimen. If patients can be switched to once-a-day 
medication and safely stabilized, then they should ex¬ 
perience better compliance which would lead to more ef¬ 
fective blood pressure control. 
Although this study did show a significant rela¬ 
tionship between compliance percentage and regimen, the 
small size of the sample may have diminished statistical 
differences between other study factors. In addition, 
the source of information, pharmacy patient profiles, 
lacked data for certain variables. These missing data 
included health knowledge of subject, patient's understand¬ 
ing of his medication regimen, patient's marital adjustment, 
whether the subject properly monitored his blood pressure, 
and if the physician may have given the patient oral 
instructions different from the written prescription. 
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No statement of their impact on compliance percentage in 
this study is founded. 
The effect of age on compliance was also limited in 
the study because of the sparsity of data. However, a 
univariate ANOVA model (n=18) examing compliance rate and 
age found no significant relationship between these two 
variables. Other authors stated that the elderly were 
more compliant (5). 
Further research is indicated on the possible relation 
ships of other factors (side effects, cost of medications, 
and patient's understanding of regimen) and their affect 
on compliance percentage, not only to produce new findings 
but also to add support to the findings of this study. 
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